Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and antiviral drugs. Its structure supports the formation of stereoselective bonds, making it valuable in asymmetric synthesis. The difluorinated pyrrolidine core enhances metabolic stability and bioavailability in final drug compounds. Commonly employed in medicinal chemistry for optimizing lead compounds in drug discovery programs targeting chronic diseases.